FDA Investigator: Samuel T. Walker
- Samuel T. Walker first started conducting FDA inspections in 2000, with the last inspection in 2005. Over that time, Samuel T. Walker has conducted 31 inspections at 27 companies across 27 sites.
Get Samuel Walker's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 ULTRAtab Laboratories, Inc., Highland | 2005
Out-of-stock
Samuel T. Walker
Human Drug Form 483
FDA 483 Actilab Pharma Inc., Dorval | 2005
Out-of-stock
Samuel T. Walker
Human Drug Form 483
FDA 483 Questcor Pharmaceuticals, Inc., Charlottetown | 2005
Out-of-stock
Samuel T. Walker
Human Drug Form 483
FDA 483 Questcor Pharmaceuticals, Inc., Charlottetown | 2005
Out-of-stock
Samuel T. Walker
Human Drug Form 483
FDA 483 Par Pharmaceutical Inc., Spring Valley | 2005
Out-of-stock
Samuel T. Walker
Human Drug Form 483
FDA 483 Kronos Canada, Inc., Varennes | 2004
Out-of-stock
Samuel T. Walker
Human Drug Form 483
FDA 483 Silarx Pharmaceutical, Inc., Carmel Hamlet | 2003
Out-of-stock
Samuel T. Walker
Human Drug Form 483
FDA 483 Perrigo New York, Bronx | 2003
Out-of-stock
Samuel T. Walker
Animal Drugs & Feed Form 483
FDA 483 Novartis Pharmaceuticals Corp., Suffern | 2003
Out-of-stock
Samuel T. Walker
Human Drug Form 483
FDA 483 Barr Laboratories, Inc. (subsidiary of Teva Pharmaceuticals), Pomona | 2002
Out-of-stock
Samuel T. Walker
Human Drug Form 483
FDA 483 Silarx Pharmaceutical, Inc., Carmel Hamlet | 2002
Out-of-stock
Samuel T. Walker
Human Drug Form 483
FDA 483 Novapharm Ltd., Toronto | 2002
Out-of-stock
Samuel T. Walker
Human Drug Form 483
FDA 483 Pillar5 Pharma Inc., Arnprior | 2002
Out-of-stock
Samuel T. Walker
Human Drug Form 483
FDA 483 Lilly Analytical Research Lab, Scarborough | 2002
Out-of-stock
Samuel T. Walker
Human Drug Form 483
FDA 483 Merck KGaA, Darmstadt | 2001
Out-of-stock
Samuel T. Walker
Human Drug Form 483
FDA 483 E. Merck, Gernsheim | 2001
Out-of-stock
Samuel T. Walker
Human Drug Form 483
FDA 483 Apoteket AB Central Laboratory, Stockholm | 2001
Out-of-stock
Samuel T. Walker
Human Drug Form 483
FDA 483 Apoteket AB Produktion & Laboratorier, Goteborg | 2001
Out-of-stock
Samuel T. Walker
Human Drug Form 483
FDA 483 Pfizer Inc, Rouses Point | 2000
Out-of-stock
Samuel T. Walker
Human Drug Form 483
FDA 483 Watson Laboratories, Inc., Carmel Hamlet | 2000
Out-of-stock
Samuel T. Walker
Human Drug Form 483
FDA 483 Pfizer, Ltd., Sandwich, Kent | 2000
Out-of-stock
Samuel T. Walker
Human Drug Form 483
FDA 483 Rhodia Mulhouse Dornach, Mulhouse | 2000
Out-of-stock
Samuel T. Walker
Human Drug Form 483
FDA 483 Global Encapsulation Inc. o.b.a. GelCell, Windsor | 2000
Out-of-stock
Samuel T. Walker
Human Drug Form 483
FDA 483 Experchem Laboratories Inc., North York | 2000
Out-of-stock
Samuel T. Walker
Animal Drugs & Feed Form 483
FDA 483 Emisphere Technologies, Inc., Tarrytown | 2000
Out-of-stock
Samuel T. Walker
Human Drug Form 483
Co-Investigators (19)
- Paul C. Mouris, FDA Investigator
- Demitria J. Xiradakis, FDA Investigator
- Anthony C. Warchut, FDA Investigator
- Philip F. Istafanos, FDA Investigator
- Michael R. Dominick, FDA Investigator
- Matthew A. Spataro, FDA Investigator
- Simone E. Pitts, FDA Investigator
- Phyllis J. Wilson, FDA Investigator
- Verlinda A. Narcisse, FDA Investigator
- L G. Massimilla, FDA Investigator
- Winston R. Alejo, FDA Investigator
- Susan F. Laska, FDA Investigator
- Paraluman S. Leonin, FDA Investigator
- Perry T. Nichols, FDA Investigator
- Yvonne E. Lozano, FDA Investigator
- Peter Abel, FDA Investigator
- Donald G. Gordon, FDA Investigator
- Karen K. Takahashi, FDA Investigator
- Devaughn Edwards, FDA Investigator